These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 17897949)

  • 1. Three-dimensional structure of the EphB2 receptor in complex with an antagonistic peptide reveals a novel mode of inhibition.
    Chrencik JE; Brooun A; Recht MI; Nicola G; Davis LK; Abagyan R; Widmer H; Pasquale EB; Kuhn P
    J Biol Chem; 2007 Dec; 282(50):36505-13. PubMed ID: 17897949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of the interactions between the EphB2 receptor and SNEW peptide variants.
    Ma B; Kolb S; Diprima M; Karna M; Tosato G; Yang Q; Huang Q; Nussinov R
    Growth Factors; 2014 Dec; 32(6):236-46. PubMed ID: 25410963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced EphB2-Specific Peptide Inhibitors through Stabilization of Polyproline II Helical Structure.
    Tennett JC; Epstein SR; Sawyer N
    ACS Chem Biol; 2024 Jun; 19(6):1214-1221. PubMed ID: 38739742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure of the ligand-binding domain of the EphB2 receptor at 2 A resolution.
    Goldgur Y; Paavilainen S; Nikolov D; Himanen JP
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2009 Feb; 65(Pt 2):71-4. PubMed ID: 19193989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure and thermodynamic characterization of the EphB4/Ephrin-B2 antagonist peptide complex reveals the determinants for receptor specificity.
    Chrencik JE; Brooun A; Recht MI; Kraus ML; Koolpe M; Kolatkar AR; Bruce RH; Martiny-Baron G; Widmer H; Pasquale EB; Kuhn P
    Structure; 2006 Feb; 14(2):321-30. PubMed ID: 16472751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Ephb2 Receptor Uses Homotypic, Head-to-Tail Interactions within Its Ectodomain as an Autoinhibitory Control Mechanism.
    Xu Y; Robev D; Saha N; Wang B; Dalva MB; Xu K; Himanen JP; Nikolov DB
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repelling class discrimination: ephrin-A5 binds to and activates EphB2 receptor signaling.
    Himanen JP; Chumley MJ; Lackmann M; Li C; Barton WA; Jeffrey PD; Vearing C; Geleick D; Feldheim DA; Boyd AW; Henkemeyer M; Nikolov DB
    Nat Neurosci; 2004 May; 7(5):501-9. PubMed ID: 15107857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cupredoxin-cancer interrelationship: azurin binding with EphB2, interference in EphB2 tyrosine phosphorylation, and inhibition of cancer growth.
    Chaudhari A; Mahfouz M; Fialho AM; Yamada T; Granja AT; Zhu Y; Hashimoto W; Schlarb-Ridley B; Cho W; Das Gupta TK; Chakrabarty AM
    Biochemistry; 2007 Feb; 46(7):1799-810. PubMed ID: 17249693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural and biophysical characterization of the EphB4*ephrinB2 protein-protein interaction and receptor specificity.
    Chrencik JE; Brooun A; Kraus ML; Recht MI; Kolatkar AR; Han GW; Seifert JM; Widmer H; Auer M; Kuhn P
    J Biol Chem; 2006 Sep; 281(38):28185-92. PubMed ID: 16867992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EphB receptor-binding peptides identified by phage display enable design of an antagonist with ephrin-like affinity.
    Koolpe M; Burgess R; Dail M; Pasquale EB
    J Biol Chem; 2005 Apr; 280(17):17301-11. PubMed ID: 15722342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Shb scaffold binds the Nck adaptor protein, p120 RasGAP, and Chimaerins and thereby facilitates heterotypic cell segregation by the receptor EphB2.
    Wagner MJ; Hsiung MS; Gish GD; Bagshaw RD; Doodnauth SA; Soliman MA; Jørgensen C; Tucholska M; Rottapel R
    J Biol Chem; 2020 Mar; 295(12):3932-3944. PubMed ID: 32060095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal structure of an Eph receptor-ephrin complex.
    Himanen JP; Rajashankar KR; Lackmann M; Cowan CA; Henkemeyer M; Nikolov DB
    Nature; 2001 Dec 20-27; 414(6866):933-8. PubMed ID: 11780069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EphB2 activity plays a pivotal role in pediatric medulloblastoma cell adhesion and invasion.
    Sikkema AH; den Dunnen WF; Hulleman E; van Vuurden DG; Garcia-Manero G; Yang H; Scherpen FJ; Kampen KR; Hoving EW; Kamps WA; Diks SH; Peppelenbosch MP; de Bont ES
    Neuro Oncol; 2012 Sep; 14(9):1125-35. PubMed ID: 22723427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An efficient bioorthogonal strategy using CuAAC click chemistry for radiofluorinations of SNEW peptides and the role of copper depletion.
    Pretze M; Kuchar M; Bergmann R; Steinbach J; Pietzsch J; Mamat C
    ChemMedChem; 2013 Jun; 8(6):935-45. PubMed ID: 23559494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered expression patterns of EphrinB2 and EphB2 in human umbilical vessels and congenital venous malformations.
    Diehl S; Bruno R; Wilkinson GA; Loose DA; Wilting J; Schweigerer L; Klein R
    Pediatr Res; 2005 Apr; 57(4):537-44. PubMed ID: 15718372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An investigation of binding interactions of tumor-targeted peptide conjugated polyphenols with the kinase domain of ephrin B4 and B2 receptors.
    Mitchell SM; Heise RM; Murray ME; Lambo DJ; Daso RE; Banerjee IA
    Mol Divers; 2024 Apr; 28(2):817-849. PubMed ID: 36847923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis and characterization of novel small molecular inhibitors of ephrin-B2 binding to EphB4.
    Duggineni S; Mitra S; Noberini R; Han X; Lin N; Xu Y; Tian W; An J; Pasquale EB; Huang Z
    Biochem Pharmacol; 2013 Feb; 85(4):507-13. PubMed ID: 23253822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NMR structure and dynamics of human ephrin-B2 ectodomain: the functionally critical C-D and G-H loops are highly dynamic in solution.
    Ran X; Qin H; Liu J; Fan JS; Shi J; Song J
    Proteins; 2008 Aug; 72(3):1019-29. PubMed ID: 18300229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of the Receptor Tyrosine Kinase EphB2 on Dendritic Cells Is Modulated by Toll-Like Receptor Ligation but Is Not Required for T Cell Activation.
    Mimche PN; Brady LM; Keeton S; Fenne DS; King TP; Quicke KM; Hudson LE; Lamb TJ
    PLoS One; 2015; 10(9):e0138835. PubMed ID: 26407069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Manipulation of EphB2 regulatory motifs and SH2 binding sites switches MAPK signaling and biological activity.
    Tong J; Elowe S; Nash P; Pawson T
    J Biol Chem; 2003 Feb; 278(8):6111-9. PubMed ID: 12486127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.